28P - ODM-208, a novel CYP11A1-inhibitor as a therapeutic approach for the treatment of castration-resistant prostate cancer

Autor: Oksala, R. 1, Karimaa, M. 1, Ramela, M. 1, Riikonen, R. 1, Huhtaniemi, R. 2, Rummakko, P. 3, Wohlfahrt, G. 3, Vuorela, A. 3, Mustonen, M.V. 4, Kallio, P. 1
Zdroj: In Annals of Oncology September 2017 28 Supplement 5:v8-v8
Databáze: ScienceDirect